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The peritoneal spreading of gastric and colorectal cancers represents a frequent 
event occurring after curative resection (Sadeghi et al. 2000, Jaine et al. 2002). 
Critical for the peritoneal recurrence is the adhesion of the free disseminated cancer 
cells to the mesothelial layer and many different molecular mechanisms directly 
involved in this process have been identified. For peritoneal carcinomatosis, cancer 
cells must be able to survive in the peritoneal cavity, once detached from the 
primary tumor, and must display a proliferative and invasive behaviour, once 
adhered to the mesothelium.  
The first step in the development of peritoneal carcinomatosis is the detachment of 
tumour cells from the primary cancer, a spontaneous shedding of loose cell like a 
result of rapid tumor cell proliferation (Hayashi et al., 2007). Once detached, cells 
are transported through the peritoneal cavity along predictable routes. Both of 
these carcinomas can spread to other organs with haematogenous metastasis, 
regional lymph node metastasis and peritoneal dissemination (Pantel et al., 2008). 
The interaction between the forces of gravity, diaphragmatic excursion, mesenteric 
reflections, and peritoneal recesses results in a flow directed towards the pelvis and 
from the pelvis, along the right paracolic gutter, towards the subdiaphragmatic 
space. Moreover, cancer cells have inherent motility provided by lamellipodia and 
filipodia; cell structures that generate force by polymerisation of actin 
microfilaments, a process stimulated by the binding of growth factors to the 
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membrane (Celeen et al., 2009). Loose cancer cells can adhere to mesothelial cells, 
the extracellular matrix, or to specialised structures, such as the omentum and the 
diaphragmatic peritoneum.  
 
1.1  Role of mesothelial microenvironment in the peritoneal 
dissemination 
 
Adhesion of cancer cells to the mesothelial layer is mediated by several adhesion 
molecules, many of which are also expressed by endothelial cells (Table 1).  
Many studies have been addressed to the analysis of the expression and activation 
of molecular pathways responsible for the sequential biological changes of the 
different types of cancer cells (Harada et al. 2001, Kajiyama et al. 2008, Saito et al. 
2010).  
Numerous Authors have demonstrated that adhesion of tumour cells to the 
hyaluronan pericellular coat of mesothelial cells is an important step in the 
peritoneal spread of ovarian and colorectal cancer (Casey et al., 2003). 
A wide variety of malignancies of epithelial and mesenchymal origin express high 
levels of the hyaluronan receptor CD44. Blocking interaction of CD44 with 
hyaluronan using antisense CD44 cDNA monoclonal antibodies that block the 
hyaluronan binding site of CD44, intact hyaluronan and hyaluronan oligomers, 
reduced cell adhesion and inhibited cell migration. However, because blocking 
CD44 did not totally inhibit mesothelial binding in all studies, it is likely that other 
surface molecules are involved (Cannistrà et al., 1993; Casey et al., 2003). 
 
ECM components Urokinase plasminogen 
activator (uPA) and its 
receptor (uPAR), 
Vitronectin 
Madsen et al, J Cell Biol, 2007 
Heyman et al, Tumor Biol, 2008 
Integrins α2, α3, α5 and β1  Saito et al, Clin Exp Metastasis, 2010 
Felding, Clin Exp Metastasis, 2003 
Takatsuki et al, Cancer Research, 2004 
ECM components Laminin-5 Saito et al, Clin Exp Metastasis, 2010 
Nakashio et al, Int. J. Cancer, 1997 
Metalloproteinases MMP-9 Saito et al, Clin Exp Metastasis,2010 
Kim et al, Anticancer Res, 2004 
Antigens CEA (Carcinoembrionic 
antigen) 
Tomita et al, Immunology, 1974 
Growth Factor TGF-β1 Nakashio et al, Int. J. Cancer, 1997 
Cell adhesion 
molecule (CAM) 
CD44H, CD44E, CD133, 
ICAM-1, VCAM-1, 
PECAM 
Nakashio et al, Int. J. Cancer, 1997 
Orian, Eur J Cancer, 2010 
Jayne et al, Clin Exp Metastasis, 1999 
Haraguchi et al, Ann Surg Oncol, 2008 
Takatsuki et al, Cancer Research, 2004 
ECM components Hyaluronic acid Nakashio et al, Int. J. Cancer, 1997 
ECM components Collagen 1and 4 Nakashio et al, Int. J. Cancer, 1997 
Jayne et al, Clin Exp Metastasis, 1999 
ECM components Fibronectin Nakashio et al, Int. J. Cancer, 1997 
Cytokines TNF-α, IL-1β, IL-6, IL-8 Jayne et al, Clin Exp Metastasis, 1999 
Mochizuchi et al, Clin Exp Metastasis, 
2004 









The role of integrins in the interaction of tumour cells with mesothelial cells has 
also been explored. Lessan et al. demonstrated that is possible reduce adhesion of 
an ovarian carcinoma cell line to mesothelial cells by using a monoclonal antibody 
against the 1 integrin subunit, which is common to many integrin molecules and 
can bind a variety of ECM proteins (Casey et al., 2003)  
Migration of ovarian carcinoma cell lines towards fibronectin, type IV collagen and 
laminin can be blocked by antibodies against 51, 21 and 61, respectively. 
Equally, antibodies against CD44 reduced cell adhesion and migration, suggesting 
that tumour migration is regulated by both integrin-dependent and independent 
mechanisms (Jones et al., 1995; Casey et al., 2003) 
Although mesothelial cells appear to mainly promote tumour dissemination and 
growth, intact hyaluronan inhibits the adhesion of tumour cells to mesothelium. 
Similarly, conditioned medium from a confluent mesothelial cell culture containing 
high amounts of hyaluronan prevented tumour cell attachment to mesothelial cells, 
but hyaluronidase treatment increased tumour cell adhesion. Free hyaluronan in 
the conditioned medium would have bound to the CD44 molecules on the tumour 
cells and blocked their interaction with the hyaluronan present on the surface of the 
mesothelial cells.  
Removal of free hyaluronan may explain why tumour cells adhere to mesothelial 
cells in other studies. Therefore, under normal physiological conditions, secretion 
of hyaluronan by mesothelial cells into the serosal fluid may protect the serosal 
surface from tumour implantation.  
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A limited number of reports have focused on the contribution of the mesothelial 
layer in the adhesion and peritoneal spreading of the cancer (Casey et al. 2003, 
Takatsuki et al. 2004, Alkhamesi et al. 2005). However, as discussed, mesothelial 
cells synthesize a host of growth factors in response to inflammatory stimuli and, 
therefore, may play a role in stimulating tumour growth. Several experimental 
studies have demonstrated that, following surgical trauma, tumour growth is also 
enhanced at sites distal to the injury (Bouvy et al., 1997; van den Tol et al., 1998). In 
addition, increased tumour growth was observed in animals exposed to surgical 
wound fluid or a combination of the growth factors TGF- and bFGF, suggesting 
that mediators produced after surgical trauma enhance local and distant tumour 
growth (Hofer et al., 1998). It is likely that these mediators induce upregulation of 
cell adhesion molecules on mesothelial cells, promoting tumour cell attachment. 
Once the tumour cells adhere to mesothelial cells, they can migrate through the 
mesothelium, invade local organs and move to distant sites. Interleukin-1, TNF- 
and IFN- upregulate adhesion molecule expression on mesothelial cells and IL-1 
and EGF increase tumour cell adhesion to cultured mesothelial cells. Adhesive 
interactions were also reported between the mesothelial hyaluronan coat and the 
transmembrane glycoprotein CD44, a molecule expressed by many cancer types.  
Interactions have been noted between chemokine receptors present on the cancer 
cells and mesothelial targets. Examples include binding of CXCR4 to stromal cell-
derived factor 1 (SDF-1) and binding of MUC16 to mesothelin. In areas of absent or 
contracted mesothelial cells, interaction between cancer cells and the underlying 
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extracellular matrix components—laminin and fibronectin—seems mainly 
mediated by the 1 integrin subunit.   
Resting mesothelial cells have been shown to express vascular, intercellular, and 
platelet endothelial cell adhesion molecules (VCAM-1, ICAM-1, and PECAM-1). 
Experimental evidence showed that, in vitro, adhesion is mediated by the 
interaction of mesothelial ICAM-1 and CD43 of tumor cells (sialophorin) rather 
than 2 integrin, the most ubiquitous ligand of ICAM-1 (Celeen et al. 2009).  
For the detailed analysis of the molecular mechanisms affecting the adhesive stage, 
different in vitro or ex-vivo models have been developed (Jayne et al. 1999, 
Cabourne et al. 2010) and primary cultures of mesothelial cells have been obtained 
to test the adhesion of cancer cells in presence of promoting or interfering agents 
(Casey et al. 2003, Heyman et al. 2008). Most of these models utilize either 
established cell lines or human primary cultures of mesothelial cells isolated from 
omental fragments (Yung et al. 2006, Sikkink et al. 2009). However, it has been 
proposed that also the peritoneal lavages are a good and more practical source of 
mesothelial cells to be propagated in vitro (Ivarsson et al. 1998), although their use 
in co-culture models has not been explored.    
Adhesion molecules play a major role in the step involving the attachment of the 
free cancer cells to the peritoneal surface (Celeen et al. 2009) and cytokines, such as 
interleukin 1b (IL1b and tumor necrosis factor  (TNF) released in the 
inflammatory microenvironment, are known to promote their expression (Van 
Grevenstein et al. 2007, Ziprin et al. 2003). Among the adhesion molecules which 
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play a key role in the spreading of the neoplastic cells to the mesothelial monolayer, 
several studies pointed to the specific function of the intercellular adhesion 
molecule 1 (ICAM1) present on the mesothelial cells in promoting the process 
(Alkhamesi et al. 2005, Ziprin et al. 2003); in addition, it has been shown that the 
up-modulation of its expression, as a result of oxidative stress and senescence of the 
peritoneal cells, promotes the adhesion of neoplastic cells from ovarian, gastric and 
colon cancers (Ksiazek et al. 2008, 2009, 2010), demonstrating the general and 
crucial role of ICAM1 in the spreading. 
 
1.2  Role of tumoral counterpart in the peritoneal dissemination: the free 
peritoneal tumor cells (FPTCs) 
 
The role played by the tumoral counterpart in gastric cancer and colorectal cancer 
represent the other side of the carcinomatosis disease.  
The peritoneal dissemination is more frequent in gastric cancer than in colorectal 
cancer and is due to the detachment of epithelial cells from primary solid tumor 
(Khair et al. 2007, Pantel et al. 2008).  
Peritoneal dissemination by primary gastric and colorectal tumor is an important 
step in metastatic cascade and free cancer cells have been detected by cytological 
examination of peritoneal washes (Hayes et al. 1999).  
The success of surgical treatment in patients with gastric and colorectal cancer is 
often limited. This is because of local recurrence or the development of distant 
metastases or peritoneal carcinomatosis by cells that have already been seeded at 
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the time of operation but cannot be detected using conventional diagnostic tools. 
The elimination of these micrometastatic cells is the aim of various adjuvant 
therapies (Hagiwara et al. 1992, Moertel et al. 1990); therefore, it is very important 
to examine the presence or absence of free cancer cells in the peritoneal cavity at the 
time of surgery (Bando et al. 1999, Kodera et al. 1999). However, it remains unclear 
if single tumor cells are of prognostic significance and have the ability to form 
metastatic disease.  
Peritoneal lavage cytology is the gold standard for assessing the presence of 
peritoneal dissemination of gastric and colorectal cancer, but its sensitivity is 
relatively low, ranging 14-21% in gastric cancer involving the serosa (Juhl et al. 
1994, Wu et al. 1997, Benevolo et al. 1998). Recently, several new methods for 
detecting micrometastasis, including immunochemical and biological methods 
have been developed (Nekarda et al. 1999, Kodera et al. 2002, Sakakura et al. 2004). 
Among other techniques, immunocytochemistry and real time quantitative reverse-
transcriptase polymerase chain reaction (qRT-PCR) techniques have been used to 
improve the sensitivity of this method (Benevolo et al. 1998). Molecular 
characterization by real-time qRT-PCR of cellular tumour markers could contribute 
to understand the role of tumour dormant cells and have a good prognostic value 
in patients with colorectal and gastric cancer after curative surgery (Baba et al. 
1989). Recently, molecular diagnosis with real-time qRT-PCR was performed to 
detect free cancer cells from peritoneal washing in patients with advanced gastric 
cancer (Kodera et al. 1998).  
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The carcinoembryonic antigen (CEA), cytokeratin-20 (CK20) and cytokeratin-19 
(CK19) are the most common target for real-time qRT-PCR amplification in 
peritoneal washes from gastric cancer patients (Katsuragi et al. 2007). In particular, 
CEA and CK20 evaluated with multivariate analysis represent independent 
prognostic markers (Oyama et al. 2004). However, it has been also argued that the 
detection of these markers by RT-PCR-based methods is of limited value because 
both CEA and CK20 can be expressed and released by hematopoietic cells in the 
inflammatory context (Kowalewska et al. 2008). 
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2. High adhesion of cancer cells to mesothelial monolayer 




In the attempt to better define the mesothelial contribution to the adhesion of 
cancer cells and, in particular, the possible role of the mesothelial activation in a 
cancerous environment mimicking in vitro as much as possible the in vivo 
conditions, we used here a direct adhesion test performed on human primary 
cultures of mesothelial cells (HPMCs) derived from the peritoneal washes of 
patients with gastric and colorectal tumors or of patients with benign diseases, in 
order to mimic in vitro as much as possible the in vivo conditions. With the aim to 
minimize the possible variations attributable to the tumor counterpart, we matched 
different isolated HPMCs, grown also at different levels of senescence, with two 
well known cancer cell lines. Our results show that the adhesive behaviour of the 
cancer cells is not affected by the origin of the HPMCs from patients with different 
tumors. However, our observations confirm the role of the peritoneal senescence, 
through the enhanced production of reactive oxygen species and of ICAM1 
expression, in promoting the tumor cell adhesion (Ksiazek et al. 2008, 2009, 2010) 
and suggest that the use of the peritoneal washes as a source to isolate and 
propagate HPMCs can be easily applied to evaluate in vitro the state of the 
mesothelium in cancer patients. 
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2.2 Materials and methods 
 
 
2.2.1 Cell lines 
 
The human mesothelial MeT-5A cell line was cultured in Dulbecco’s modified 
eagle’s/F12 medium (DMEM/F12) supplemented with 10% fetal bovine serum 
(FBS) plus antibiotics and hydrocortisone (0,1 g/ml), insulin (2,5 g/ml), 
transferrin (2,5 g/ml) and selenium (2,5 ng/ml) (Sigma Chemicals Co., St Louis, 
MD, USA). The human colorectal adenocarcinoma Caco2 cell line was cultured in 
Dulbecco’s Modified Eagle’s Medium (DMEM) supplemented with 10% FBS plus 
antibiotics (Sigma). The human gastric adenocarcinoma AGS cell line was cultured 
in Ham’s F12 medium (Sigma) supplemented with 10% FBS plus antibiotics 
(Sigma). 
  
2.2.2 Primary cultures 
 
Primary cultures of Human Peritoneal Mesothelial Cells (HPMCs) were obtained 
from intraoperatively peritoneal lavages of patients affected by colorectal cancer (n. 
48), gastric cancer (n. 27) and non-cancerous diseases (n. 6), who underwent 
surgery between December 2008 and December 2009 at the A Unit of Surgery of 
Sant’Andrea Hospital.  
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All patients were extensively informed and gave written consent for the 
investigation. To avoid possible activation of the peritoneal cells by the surgical 
process, the peritoneal lavages were obtained at the starting steps of the surgery.  
From each patient, 40 mL of peritoneal wash were collected in EDTA (50 M).  
The peritoneal washes were centrifuged at 1100 rpm for 5 minutes at RT and 
pelletted. Samples were resuspended for magnetic labeling in 80 µL of MACS 
separation buffer (Miltenyi Biotec, Bergisch Gladbach, Germany). To remove 
epithelial cell component from the peritoneal wash and consequently to enrich the 
mesothelial portion, immunomagnetic depletion using anti-CD326/EpCAM 
microbeads (Miltenyi Biotec, Bergisch Gladbach, Germany) was performed 
according to the manufacturer’s instructions.  
Briefly, MS separation columns (MACS, Miltenyi Biotec) had been equilibrated 
with 0,5 mL of MACS separation buffer and the microbeads labeled cells were 
subjected to magnetic field trough the column passage. The CD326 negative cells 
were washed off from the column, and were plated in DMEM/F12 as above. 
For the adhesion experiments, we have used three representative HPMCs primary 
cultures: #Ctrl2 (from a patient with non-cancerous disease), #062 (from a patient 
affected by colon cancer) and #219 (from a patient affected by gastric cancer). The 




2.2.3 Co-cultures  
 
For co-culture experiments, MeT-5A or HPMCs were grown to confluence and after 
24h Caco2 or AGS cells were seeded on the monolayer.  
 
2.2.4 Immunofluorescence  
 
For HPMCs characterization cells were grown on coverslips and fixed with 4% 
paraformaldehyde followed by treatment with 0,1 M glycine for 20 minutes at 25°C 
and with 0,1% Triton X100 for an additional 5 minutes at 25°C to allow 
permeabilization. Cells were then incubated for 1 hour at 25°C with the following 
primary antibodies: anti-cytokeratins (recognizing CK8 and CK19 among other 
CKs) (1:100 in PBS; clone MNF116; Dako, Glostrup, Denmark) monoclonal 
antibody; anti-vimentin (1:100 in PBS; clone V9; Dako) monoclonal antibody; anti-
calretinin (1:100 in PBS; clone DAK Calret 1; Thermo Fisher Scientific Inc., Fremont, 
CA, USA) monoclonal antibody; anti-CEA (1:100 in PBS; Zymed, Invitrogen, 
Carlsbad, CA, USA) polyclonal antibodies; anti-EpCAM (1:10 in PBS; Miltenyi 
Biotec GmbH, Bergisch Gladbach, Germany) monoclonal antibody directly 
conjugated with PE; anti-ICAM1 (1:10 in PBS; Stemcell Technologies, Vancouver, 
BC, Canada) monoclonal antibody directly conjugated with FITC.  
The unconjugated primary antibodies were visualized, after appropriate washing 
with PBS, using goat anti-mouse FITC (1:50 in PBS; Cappel Research Products, 
Durham, NC), goat anti-mouse Texas Red (1:200 in PBS; Jackson Immunoresearch 
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Laboratories, West Grove, PA, USA), goat anti-rabbit  FITC (1:400 in PBS; Cappel 
Research). To identify cycling cells, immunostaining was performed with anti-Ki67 
rabbit polyclonal antibodies (1:50 in PBS; Zymed Laboratories, San Francisco, CA). 
Nuclei were stained with 4’,6-diamidino-2-phenylindole (DAPI) (1:10.000 in PBS; 
Sigma). Coverslips were finally mounted with 90% glycerol in PBS for observation. 
Fluorescence signals were visualized with the ApoTome System (Zeiss, 
Oberkochen, Germany) connected with an Axiovert 200 inverted microscope 
(Zeiss) and image analysis was performed by the Axiovision software (Zeiss) and 
KS300 Image processing system (Zeiss). 
Percentage of EpCAM/Ki67-positive cells in co-cultures of MeT-5A and AGS or 
Caco2 cells was analyzed counting a total of 500 cells randomly observed in 5 
microscopic fields for each different time points (1h,  24h, 48h) during the time 
course of the experiment. 
Percentage of ICAM-1-positive cells in HPMCs was analyzed counting for each 
primary culture a total of 300 cells, randomly observed in 10 microscopic fields 
from three different experiments. Quantitative analysis of the ICAM-1 fluorescence 
intensity was performed by the analysis of 100 cells for each sample in five different 
fields, randomly taken from three different experiments.  
All results were expressed as mean values ± SE. Significance was calculated using 




2.2.5 Adhesion assay 
 
Subconfluent Caco2 or AGS cells were trypsinized and resuspended in DMEM 
serum free and labeled with 5 l/ml of Vybrant®DiI solution (Invitrogen, Carlsbad, 
CA, USA) by incubation for 30 minutes at 37°C. The DiI-labeled cells were washed 
three times and resuspended in DMEM/F12 as above. The labeled-cells were 
directly plated on the mesothelial monolayer (25X103/cm2 of monolayer)  and 
incubated for 1, 24, 48 hours. In the adhesion assays with the anti-ICAM1 blocking 
antibody (Stemcell Technologies), the incubation was performed in the presence of 
different dilutions (1:10, 1:5, 1:2) of the antibody (specificare I tempi). Non-adherent 
cells were removed by abundant washes with serum free medium, and adherent 
cells and HPMCs monolayers were fixed with 4% paraformaldehyde, followed by 
treatment with 0.1M glycine for 20 minutes at 25°C and with 0.1% Triton X-100 for  
additional 5 minutes at 25°C to allow permeabilization. Nuclei were stained with 
DAPI.  Nuclei were stained with DAPI (4,6-diamidino-2-phenylindol) (1:10.000 in 
PBS; Sigma).  
Quantitative analysis of DiI-positive cells/mm2 was performed by counting the 
number of positive cells in 10 different optical fields of 2,24 mm2, randomly taken 
from three different experiments. Results have been expressed as mean values ± SE. 
P values were calculated using Kruskal-Wallis test and significance level was 
defined as p<0,05. 
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2.2.6. Reactive oxygen species detection 
 
For reactive oxygen species (ROS) detection, HPMCs cells were incubated with 
2’,7’-dichlorofluorescein diacetate (DCFH-DA, Fluka) (5 M) for 10 min at 37°C, 
washed extensively with PBS and immediately observed under an Axioskop 2 
microscope equipped with Pascal LSM 5 confocal laser scan (Zeiss, Oberkochen, 
Germany) using an argon laser with a 488 nm excitation band. The emission long 
pass was a 505 filter: laser intensity, pinhole diameter and photomultiplier settings 
were kept constant for every experiment. Fluorescence images were analyzed by 
KS300 (Zeiss). The fluorescence intensity was measured by image analysis 
evaluating at least 200 cells for each condition in three different microscopic fields. 
The data presented are expressed as mean values ± SE from three different 
experiments. Statistical analysis was performed using Student’s t test and 




2.3.1 Optimization of the in vitro test for evaluation of the adhesion of cancer cells to the 
mesothelial monolayers 
 
One of the first key step in peritoneal metastatic dissemination of gastrointestinal 
tumours is the adhesion of cancer cells to the mesothelial monolayer (4). To study 
the biological behaviour of both cancer and mesothelial cells and to evaluate their 
properties of adhesion, we first selected and adapted to our conditions a co-culture 
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system and an in vitro test for adhesion (Fig. 1A), previously used for ovarian 
cancer (12). The human mesothelial cell line MeT-5A was grown at confluence and 
human gastric adenocarcinoma cells (AGS cell line) or human colon carcinoma cells 
(Caco2 cell line) were seeded in co-culture at the density of 25.000 cells/cm2 of 
mesothelial monolayer.  
To identify the different cell types in our co-culture model, we used 
immunofluorescence (IF) microscopy. After 24 hours from seeding, to recognize the 
mesothelial cells making up the Met-5A monolayer, we stained the co-cultures with 
a primary antibody directed against vimentin, a component of the intermediate 
filaments of the cytoskeleton, followed by a secondary Ab labeled with the FITC 
fluorocrome (green): the signal was compatible with the structure and localization 
of vimentin, which appears as perinuclear cytoplasmic bundles of filaments (Fig. 
1B). The cancer cells were labeled with -EpCAM PE antibody, recognizing a 
human epithelial adhesion molecule and directly conjugated to the fluorochrome 
PE (red): the corresponding signal was associated with the plasma membrane of the 
cells adherent to the monolayer (Fig. 1B). The cellular nuclei were stained with 
DAPI (blue). Both AGS and Caco2 cells appeared either in small clusters or isolated 
and strictly adherent to the mesothelial cells (Fig. 1B). 
For the evaluation of the adhesive properties of the cancer cells, we used phase 
contrast microscopy, which allowed to verify the mesothelium monolayer and 
removed any doubt about the possibility of cancer cells adhering to the glass or 
plastic support. The morphological analysis after 48 hours from seeding showed 

Figure 1. Co-culture in vitro test for the adhesion of cancer cell lines to 
mesothelial monolayer. 
A) Schematic drawing of the co-culture system and the adhesion test used 
throughout the study: cancer cells are seeded on a mesothelial monolayer to 
evaluate cell adhesion. 
B) MeT-5A mesothelial cell line was grown at confluence and AGS or Caco2 cells 
were seeded on the mesothelial monolayer in co-culture (25.000 cells/cm2). After 24 
hours from seeding, the co-culture was fixed, permeabilized and stained with a 
primary antibody directed against vimentin, followed by a secondary Ab labeled 
with the FITC fluorocrome (green) to identify the mesothelial cells. Double 
immunofluorescence with α-EpCAM PE antibody (red) was performed to recognize 
the cancer epithelial cells. Cellular nuclei were stained with DAPI (blue). The 
immunofluorescence analysis reveals the different cell types in our co-culture 
model. The signal corresponding to vimentin in the cell monolayer is compatible 
with that of intermediate filaments, as perinuclear cytoplasmic bundles, while the 
EpCAM staining is associated with the plasma membrane of the cancer cells. Both 
AGS and Caco2 cells appear either in small clusters or isolated and strictly adherent 
to the mesothelial cells. Bar: 10 µm 
C) Phase contrast microscopy used to verify the integrity of mesothelium 
monolayer. After 48 hours from seeding, the adherent Caco2 cells display a pattern 
of growing in compact islands, while the AGS adhering cells show a more flattened 
shape and an isolated pattern of growth. Bar: 100 µm 
D) Proliferation assay performed by immunofluorescence staining with a primary 
anti-Ki67 antibody, which identifies cycling cells, followed by a secondary FITC-
labeled Ab (green). The tumor cells were labeled with the anti-EpCAM PE Ab as 
above. After 48 hours from seeding, the distribution of the cancer cells positive for 
the Ki67 nuclear signal reveals a different behavior of tumor growth: differently 
from the isolated AGS cells, the Ki67+ Caco2 cells are located at the periphery of the 
islands. Bar: 100 µm 
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that the adherent Caco2 cells displayed a pattern of growing in compact islands 
(Fig. 1C). In contrast, the AGS adhered cells were characterized by a more flattened 
shape and a more isolated pattern of growth (Fig. 1C). 
To better understand the biological behaviour observed in phase contrast 
microscopy and to evaluate the proliferation rate of the adherent cells, we used IF 
analysis with the Ki67 marker which identifies cycling cells. After 48 hours from 
seeding, the co-cultures were stained with a primary anti-Ki67 antibody, followed 
by a secondary FITC-labeled Ab (green).  
The tumor cells were labeled with the anti-EpCAM PE Ab as above. While the 
proliferative rate of the two adhering cell types, evaluated as the percentage of the 
the cells positive for the Ki67 nuclear signal was comparable (21%2 and 23%2 for 
the Caco2 and AGS cells respectively; Kruskal-Wallis test: p=NS), their distribution 
revealed a different behaviour of the cancer cells (Fig. 1D). In fact, unlike AGS cells, 
the Ki67+ Caco2 cells were located at the periphery of the islands, as expected from 
their spontaneous ability to differentiate in vitro (Visco et al., 2004). 
For a quantitative evaluation of the adhesion of the two cancer cell lines to the MeT-
5A monolayer, we used the lipophilic cellular tracer DiI to label the cancer cells 
before the adhesion test (Heyman et al., 2008). Figure 2A shows the results obtained 
by the contemporary use of DiI and DAPI staining of the co-cultures at different 
time points (1h,  24h, 48h) from seeding. Images of 10 different optical fields were 
randomly taken as described in materials and methods. The numbers of DiI+ 
cancer cells per mm2 were then calculated and statistically analyzed as described in 

Figure 2. Adhesion test with AGS and Caco2 cells on Met-5A monolayer  
A) Met-5A mesothelial monolayer was grown as described above. Caco2 and AGS 
cells were labeled with the Dil tracer and then seeded on the monolayer as above. 
After 1, 24 and 48 hours, co-cultures were washed, fixed and permeabilized. Nuclei 
were stained with DAPI. Bar: 200 µm 
B) Quantitative analysis of the number of adherent Dil+ cells/mm2 was performed 
as described in materials and methods. While after 1 hour of seeding both Caco2 
and AGS cells adhere to the monolayer in equal amount, at the 24 and 48 hours 
time points the number of Caco2 cells is almost doubled compared to that of AGS, 
which increases only slightly but significantly over the time. Results are expressed 
as mean values ± IC 95%. Student’s t test was performed and significance levels 
have been defined a p<0,05. *p<0,001 vs the corresponding 1 hour; **p<0,001 vs the 
corresponding 1 hour and 24 hours. 
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materials and methods. The results in figure 2B showed that both Caco2 and AGS 
cells were adhering to the mesothelial monolayer in equal amount at 1 h of co-
culture. However, adhesion of Caco2 cells had the tendency to double after 24 and 
48 hours, while the AGS cells, although slightly but significantly increasing in 
number during the timespan, were less numerous than the Caco2 cells at either 
time points (p<0,05). Because the proliferative rate of the two cell types at 48 hours, 
as described above, did not reveal differences which may account for the higher 
number of Caco2 cells adhering to the monolayer compared to the AGS cells, the 
results of the DiI-based test appeared to reflect real differing adhesive properties. 
 
2.3.2 Adhesion of cancer cells to primary human mesothelial monolayer derived from 
peritoneal washes 
 
To assess the possible role of the mesothelium in the adhesion process of the cancer 
cells in our co-culture system, we used the above test with primary cultures of 
mesothelial cells obtained from the peritoneal wash of patients affected by 
colorectal or gastric cancer and non-carcinoma disease. In fact, the peritoneal lavage 
represents a practical source of mesothelial cells (Ivarsson et al., 1998), instead of 
utilizing omentum fragments.  
To characterize the human peritoneal mesothelial cells (HPMCs), obtained as 
described in materials and methods, we used immunofluorescence microscopy 
(Fig. 3). To recognize the primary mesothelial cells from other types of cells present 
in the peritoneal wash, such as fibroblasts and epithelial cancer cells, we stained the 
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cultures with a combination of antibodies directed against known mesothelial 
markers, such as vimentin, cytokeratins (CK8 and CK19) and calretinin. To be sure 
that the cells were of mesenchimal origin and not epithelial, we used in parallel the 
same antibodies on Caco2 cells. The results showed that the HPMCs were positive 
for both vimentin and cytokeratin staining, which appeared as perinuclear 
cytoplasmatic bundles of intermediate filaments (Fig. 3, left panels). As expected, 
Caco2 cells were negatively stained for vimentin and positively labeled for 
cytokeratins (Fig. 3, right panels). To unequivocally discriminate the HPMCs from 
fibroblasts possibly present in our cultures, cells were labeled with antibodies 
against calretinin, an intracellular calcium-binding protein belonging to the 
troponin-C superfamily expressed in mesothelial cells: the signal was in cytosolic 
hot-spots (Fig. 3, right panel). Again, the epithelial Caco2 cells were negative (Fig. 
3, left panel). In contrast, HPMCs were negative for the epithelial marker EpCAM 
which was expressed on the plasma membranes of the Caco2 cells (Fig. 3, bottom 
panels, red signal) and for the tumor marker carcinoembryonic antigen CEA, 
whose signal was visible either in intracellular spots or on the cell surfaces (Fig. 3, 
bottom panels, green signal). 
For a quantitative evaluation of the ability of the two cancer cell lines (AGS and 
Caco2 cells) to adhere to different HPMC monolayers, we used the DiI tracer as 
above to mark the cancer cells before the adhesion test. For the analysis we utilized 
three primary cultures of mesothelial cells, derived from the peritoneal washes of 
patients without carcinoma disease (Fig. 4A), with colorectal cancer (Fig. 4B) or 

Figure 3. Immunofluorescence characterization of human peritoneal mesothelial 
cells from peritoneal washes of gastric and colon cancer patients. 
Primary cultures of human peritoneal mesothelial cells (HPMCs) were isolated 
from peritoneal washes as described in materials and methods. Caco2 colon cancer 
cells were used as a control. Immunofluorescence analysis using antibodies 
directed against mesothelial (vimentin, CK8 and CK19 cytokeratins and calretinin) 
and epithelial (EpCAM and CEA) markers shows that HPMCs are positive for 
vimentin and cytokeratin staining, that appears as perinuclear bundles of filaments, 
as well as for the hot-spotted calretinin signal, but are negative for the plasma 
membrane EpCAM staining and for the intracellular and surface CEA signal. Caco2 
cells are positive for cytokeratins and double positive for the EpCAM and CEA 
epithelial markers visible on the cell surfaces (EpCAM, green signal) or on the 
plasma membranes and in intracellular spots (CEA, red signal). Nuclei were 
stained with DAPI. Bar: 20 µm 
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with gastric cancer (Fig. 4C) and we were able to compare the contribution of 
different mesothelial monolayers to the adhesion of the same type of cancer cells at 
different time points (1, 24 and 48 hours). The quantitative analysis of the adhesion 
of DiI+ cells to the HPMC monolayers (Fig. 4A-C) showed reduced levels of 
adhesion in timespan for both tumor cell lines compared to the adhesion test 
performed on MeT-5A (see Fig. 2B). On these primary cultured monolayers, the 
Caco2 cells were more adherent than AGS cells at either 24 or 48 hours, 
independently on the origin of the peritoneal washes. However, while the adhesion 
of the Caco2 cells was comparable to all mesothelial layers, irrespectively on their 
source from patients with neoplastic or benign disease, the AGS cells display 
significant differences in their behaviour, showing higher adhesion to the HPMCs 
from colon cancer patient (#062) respect to the HPMCs from either gastric cancer 
patient (#210) or from non-carcinoma disease (#Ctrl2). Thus, while the adhesion 
properties of the mesothelial monolayers appear independent on the cancer 
environment, our co-culture model is able to detect differences among the HPMCs. 
 
2.3.3 Role of HPMC senescence in the adhesion process  
 
To analyze by our model the contribution of possible cellular and molecular 
mechanisms  which may play a role in the different adhesive properties of the 
HPMCs, we focused our attention on the mesothelial senescence. In fact, among the 
physiological characteristics of the mesothelial monolayer, the senescence level of 
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HPMCs is believed to promote the adhesion of tumour cells (Ksiazek et al., 2008, 
2009, 2010). Interestingly, our HPMCs, being derived from peritoneal washes 
instead of from omentum samples, displayed already at the first in vitro passage 
the well known features of senescence, like an enlarged morphology, multiple 
nuclei and cytoplasmic vacuolization (Yung et al., 2006). Because it has been 
proposed that the peritoneal senescence correlates with an increase of the 
expression of the intercellular adhesion molecule 1 (ICAM1) on the plasma 
membrane as a consequence of the oxidative stress (Ksiazek et al., 2010), we 
wondered if we could observe differences in ICAM1 expression in our selected 
HPMCs. To this purpose, we evaluated by quantitative immunofluorescence the 
percentage of ICAM1 positive cells in HPMC monolayers after the first confluence 
comparing the three representative cultures used above: the HPMCs from colon 
cancer patient (#062), which appeared to better contribute to the adhesion of the 
cancer cells in the experiments described above (Fig. 4), showed an higher 
percentage of ICAM1 positive cells respect to the other mesothelial cells (Fig. 5A).  
In addition, since in the study of Ksiazek et al. (Ksiazek et al., 2009) senescence of 
human omentum-derived peritoneal mesothelial cells was induced in vitro to 
analyze its effect on tumour cell adhesion, we applied a similar approach inducing 
the senescence of our primary cultures by sequential passaging.  
To this aim, we compared the same primary culture of HPMCs from colon cancer 
patient at two different passages: P2, obtained by seeding after the first confluence, 
and P4, after 2 passages 1:3 from P2, as reported (Ksiazek et al., 2009). The phase 

Figure 4. Adhesion test with AGS and Caco2 cells on different HPMC 
monolayers.  
HPMCs isolated from the peritoneal wash of a non-cancer patient (A, #Ctrl2), from 
that of a colon cancer patient (B, #062) and from that of a gastric cancer patient (C, 
#219), were grown to confluent monolayer as above. Caco2 and AGS cells were 
labeled with Dil, seeded on the HPMC layers, left to adhere for different time 
points (1, 24 and 48 hours) and then washed, fixed and permeabilized. Nuclei were 
stained with DAPI. Quantitative analysis of the number of adherent Dil+ 
cells/mm2 was performed as described in materials and methods. Independently 
on the origin of the peritoneal washes, the Caco2 cells show higher levels of 
adhesion respect to AGS at 24 and 48 hours. However, while the adhesion of the 
Caco2 cells is similar to all mesothelial layers, the AGS cells display significant 
differences, showing higher adhesion to the layer #062 respect to the #219 and the 
#Ctrl2.  
Results of the quantitative analysis are expressed as mean values ± IC 95%. 
Kruskal-Wallis test: A) *p<0.05 vs the AGS 1 hour; **p<0.01 vs Caco2 1 hour, p<0.01 
vs AGS 24 hours; ***p<0.05 vs the AGS 1 hour and p=NS vs the AGS 24 hours; 
****p<0.01 vs Caco2 24 hours. B) *p<0.01 vs the AGS 1 hour; **p<0.01 vs Caco2 1 
hour, p=NS vs AGS 24 hours; ***p<0.05 vs the AGS 1 hour, p=NS 24 AGS hours; 
****p<0.01 vs Caco2 24 hours. C) *p<0.01 vs the AGS 1 hour; **p<0.01 vs Caco2 1 
hour, p<0.01 vs AGS 24 hours; ***p<0.05 vs the AGS 1 hour, p=NS 24 AGS hours; 
****p<0.001 vs Caco2 24 hours.  
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contrast microscopic analysis showed an increase in the cell size and in the number 
of vacuolated cells (Fig. 5B, arrowheads), reflecting the increase in the level of 
senescence from P2 to P4. In addition, because peritoneal senescence correlates with 
an increase of the expression of the intercellular adhesion molecule 1 on the plasma 
membrane as a consequence of the oxidative stress (Ksiazek et al., 2010), we 
confirmed the induction of senescence in our cultures by quantitative 
immunofluorescence with anti-ICAM1 antibodies (Fig. 5B): the results 
demonstrated that either the percentage of ICAM1-positive cells or the fluorescence 
intensity of the ICAM1 signal on the cell surface, assessed as described in materials 
and methods, were clearly increased from passage P2 to P4. The ICAM1-positive 
cells were larger than the negative cells in the same culture and frequently 
apperead multinucleated and vacuolated as observed also in the corresponding 
phase contrast images (Fig. 5B), further demonstrating that HPMCs at P4 were 
more senescent respect to P2. 
For an additional assessment of the senescence levels, we investigated the oxidative 
state of our P2 and P4 cultures evaluating the intracellular production of reactive 
oxigen species (ROS). To this purpose, we performed a test based on the addition of 
DCFH-DA (2’,7’-dichlorofluorescein diacetate) and fluorescence detection by 
confocal microscopy and we compared the levels of ROS production in P2 and P4 
cultures: as shown in figure 5C, the results obtained by the quantitative 
fluorescence analysis, performed as described in materials and methods, were 

Figure 5. Expression of ICAM1 and intracellular ROS production in HPMC 
monolayers during in vitro induced senescence. 
A) Quantitative evaluation of the percentage of ICAM1 positive cells in HPMC 
monolayers from the peritoneal wash of the non-cancer patient (#Ctrl2), from that 
of the colon cancer patient (#062) and from that of the gastric cancer patient (#219) 
after the first confluence (P2). The HPMCs from the colon cancer patient shows an 
higher percentage of ICAM1 positive cells respect to the other mesothelial cells. 
Results are expressed as mean values ± SE. Kruskal-Wallis test: *p<0,01 vs #Ctrl2 
and p<0,05 vs #219.  
B) Phase contrast microscopy (left panels) of #062 cultured at different passages to 
induce senescence: size enlargement and increase of vacuolated cells (arrowheads) 
from passage 2 (P2) to passage 4 (P4) confirm the enhanced level of senescence of 
P4.. Bars: 25 µm. The quantitative analysis of the percentage of ICAM1 positive cells 
in P2 and P4 passages shows the increase in the percentage of positive cells from P2 
to P4. Quantitative immunofluorescence analysis with anti-ICAM1 antibodies 
shows that both the number of ICAM1 positive cells, displaying a clear plasma 
membrane staining, and the fluorescence intensity of the signal are increased in P4 
cultures respect to P2 HPMCs. The parallel phase contrast observations show that 
the ICAM1 positive cells are enlarged and vacuolated as expected for senescent 
cells. The cellular nuclei were stained with DAPI. Results in the first graph are 
expressed as mean values ± SE. Kruskal-Wallis test: *p<0,001 vs P2. The 
quantitative evaluation of the fluorescence intensity of the ICAM1 signal was 
performed as described in materials and methods: results in the second graph are 
expressed as mean values ± IC 95%. Student’s t test: *p<0,01 vs P2.  
C) Evaluation of ROS production in HPMCs at P2 and P4 passages was performed 
with addition of DCFH-DA (2’,7’-dichlorofluorescein diacetate) and fluorescence 
detection by confocal microscopy as described in materials and methods. The 
increase in the fluorescence intensity signal of DCFH-DA in the late passage P4 
compared with the earlier P2 confirm the enhancement of ROS generation induced 
by senescence of the mesothelial cells. Results are expressed as mean values ± SE. 
Student’s t test: *p<0,001 vs P2.   
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consistent with an increase of fluorescent cells in the P4 late passage compared with 
the P2 early one, in agreement with the literature (Ksiazek et al., 2009). 
To determine if the different levels of senescence could affect the adhesion of the 
cancer cells to the mesothelial monolayers, we evaluated, through the in vitro test 
used above, the ability of the Caco2 cells to adhere to the cultures of HPMCs at the 
different passages, P2 and P4. The results obtained by the contemporary use of DiI 
and DAPI staining of the co-cultures at various time points (1h,  24h, 48h) from 
seeding, showed a significant increase in the number of cancer cells adhering to the 
late P4 respect to the early P2 passages (Fig. 6A and 6B). To ascertain the possible 
involvement of the enhanced ICAM1 expression of the senescent cells in increasing 
the adhesion, we added decreasing dilutions of an anti-ICAM1 blocking antibody 
during the time course of the adhesion test: the antibody addition led to a 
progressive dose-dependent inhibition of the cancer cell adhesion (Fig. 6C), 
revealing that the ability of the cancer cells to better interact with senescent HPMCs 
is related to the increased expression of ICAM1 on the cell plasma membranes of 
the mesothelial cells, as reported (Alkhamesi et al., 2005; Ksiazek et al., 2010). 
 
2.4 Discussion and conclusions 
 
The role of the mesothelial cells in the process of cancer spreading in the peritoneal 
cavity has been, up to now, underestimated and remain to be clarified. However, 
similarly to the emerging crucial contribution of the stromal microenvironment 

Figure 6. Adhesion test with Caco2 cells on senescent HPMC monolayer. 
A) HPMCs from the #062 peritoneal wash were cultured at P2 and P4 as described 
in figure 5. Caco2 cells were labeled with Dil, seeded on the HPMC layers, left to 
adhere for different time points (1, 24 and 48 hours) and then washed, fixed and 
permeabilized. Nuclei were stained with DAPI. 
B, C) Quantitative analysis of the number of adherent Dil+ cells/mm2 was 
performed as described in materials and methods. In B, the number of cancer cells 
adhering to the HPMC monolayer at P4 is significantly increased respect to the 
values in P2 at all time points. In C, the addition of decreasing dilutions of an anti-
ICAM1 blocking antibody at the representative 24 hours time point leads to a 
progressive dose-dependent inhibition of the cancer cell adhesion to HPMCs at P4. 
Results in B are expressed as mean values ± SE. Kruskal-Wallis test: *p<0,05 vs the 
P2 at 1 hour; **p<0,05 vs the P2 at 24 hours; ***p<0,05 vs the P2 at 48 hours. Results 
in C are expressed as mean values ± SE. Kruskal-Wallis test: *p<0,05 vs the absence 
of blocking antibody; **p<0,01 vs the antibody dilution 1:10; ***p<0,05 vs the 
antibody dilution 1:5.  
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surrounding the tumor tissue in the neoplastic progression, also the peritoneal 
layer is expected to represent a key mediator in the development of the 
carcinomatosis. The molecular mechanisms which may affect the interaction of the 
epithelial cancer cells to the mesothelium are probably quite analogous to those 
controlling the tumor cell adhesion to the endothelial layer during metastatic 
dissemination: both the fibrinolytic activity and the pattern of expression in 
adhesion molecules on the mesothelial or endothelial cells are major players in the 
process (Celeen et al., 2009; Ivarsson et al., 1998). In this paper, with the aim to 
investigate how the behaviour of mesothelial cells may differ depending on the 
tumor context of their origin as well as the possible state of activation or 
senescence, we propagated in vitro HPMCs isolated from different peritoneal 
washes of patients affected by colon or gastric cancers or from patients with benign 
diseases: in fact, the isolation of the mesothelial cells from the lavages, instead of 
from omental fragments, permits to obtain primary cultures resembling more 
closely the in vivo conditions, as suggested (Ivarsson et al., 1998). Consistent with 
what has been previously reported (Yung et al., 2006), we found that our primary 
cultures displayed all the morphological features and the marker positivity (CK8, 
CK19 and calretinin) characteristic of the mesothelial cells. 
For the adhesion test, we selected and optimized a co-culture method, previously 
proposed for ovarian cancer cells (Heyman et al., 2008), based on the quantitative 
analysis of the adhesion of DiI+ cells to the HPMCs. First we set up the test using 
the mesothelial cell line MeT-5A and, when we moved to the primary cultures, we 
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found reduced levels of adhesion of the cancer cells at all time points compared to 
the adhesion obtained with the MeT-5A monolayer, in agreement with the 
observations reported by Heyman et al. (Heyman et al., 2008) utilizing the same 
DiI-based test. Our results with the HPMC layers, showing that both the AGS 
gastric carcinoma cells and the Caco2 colon carcinoma cells did not change their 
adhesion and growth when seeded on different mesothelial monolayers, indicated 
that the adhesive behaviour of the cancer cells was not affected by the origin and 
possible activation state of the HPMCs associated with different cancers. 
To demonstrate that our cultures of HPMCs from peritoneal washes would 
represent a more reliable model of adhesion respect to other previously proposed 
with HPMCs from other sources, we first analyzed their expression of ICAM1, 
since this adhesion molecule is known to be more elevated in HPMCs from 
peritoneal wash comparing with cells from omental biopsies (Sikkink et al., 2009) 
and it has been recently reported that the increase in ICAM1 expression promotes 
the adhesion of cancer cells (Alkhamesi et al., 2005; Ksiazek et al., 2010). In 
agreement with the reported observations (Sikkink et al., 2009), our primary cells 
showed an high expression of ICAM1 at early passages of the culture, suggesting 
that these detached cells present in the peritoneal fluid in vivo may possess 
adhesive properties more pronounced respect to the peritoneal intact layer. 
Interestingly, the HPMCs from peritoneal washes analyzed in our study were 
characterized also by the typical features of senescence already at the first in vitro 
P2 passages and by quite high levels of basal ROS production. Further increase of 
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these features, i.e. ICAM1 expression and ROS generation, were obtained inducing 
in vitro senescence, as expected (Ksiazek et al., 2008, 2009, 2010). These acquired 
senescent state led to an increase in the adhesion of the cancer cells, which was 
inhibited by the addition of serial dilutions of a blocking anti-ICAM1 antibody, 
strengthening the role of ICAM1 in the adhesion process and suggesting that this 
ICAM1-mediated molecular interaction might be even more crucial for cells 
floating in the peritoneal fluid from which our cultures are derived.  
In conclusion, we suggest that the cancer environment might be not crucial for the 
peritoneal dissemination. However, we propose that the use of HPMCs from 
peritoneal washes would provide a practical and reliable tool for the in vitro 
analysis of the mesothelial molecular pathways involved in the adhesion process, 
the evaluation of the mesothelial conditions in cancer patients and the selection or 
validation of possible therapeutic strategies. 
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3.  Clinical relevance of free peritoneal tumor cells 




In the attempt to further demonstrate the diagnostic/prognostic value of the 
detection of epithelial-tumor markers in the peritoneal washes and to rule out the 
possibility of false positive results using molecular-based techniques alone, in this 
study we combined the qRT-PCR analysis with an immunomagnetic enrichment 
followed by immunofluorescence (IF) analysis, for enhancing the specificity of 
detection of the free peritoneal tumor cells (FPTCs). To this aim, the peritoneal 
washes were directed to a procedure commonly used for detection of circulating 
tumor cells CTC from blood samples (Gervasoni et al., 2008). To detect the 
disseminated epithelial cells, we used monoclonal antibody against the pan-
epithelial marker EpCAM/CD326 and to ascertain their tumor origin we used 
polyclonal antibodies against the carcinoembryonic antigen (CEA). In this setting, 
IF microscopy allowed the morphological assessment and unequivocal 
identification of the FPTCs as well as validation of the molecular analysis. This 
combined use of immunomagnetic enrichment, IF analysis and real-time qRT-PCR, 
showing a greater sensibility respect to conventional cytology, was able to permit 
the detection of free peritoneal tumor cells in both gastric and colorectal cancer and 
to determine their prognostic value for survival. 
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3.2  Materials and methods 
 
3.2.1 Patients and Surgery 
 
All patients were extensively informed and gave written consent for the 
investigations. The study was approved by the local ethical commission. Twenty-
seven gastric and 48 colorectal patients with cancer who underwent surgery 
between December 2008 and December 2009 at the A Unit of Surgery of 
Sant’Andrea Hospital were investigated.  
Patients with distal extraperitoneal rectum cancer were excluded from the study. 
Preoperative chemotherapy or radiation therapy was not performed in this series.  
Gastric cancer patients (GC) underwent subtotal gastrectomy in 15 cases, total 
gastrectomy in 8 cases and palliative surgery in 4 cases.  
Colorectal cancer patients (CRC) underwent right colectomy in 23 cases, left 
colectomy in 10 cases, anterior resection in 14 cases and palliative surgery in 1 case. 
All patients underwent open surgery.  
A control group comprised 6 patients with a variety of non-carcinoma diseases: 
benign uterus tumor, cholecystolithiasis and colic adenoma. Follow-up data were 




Immediately after a midline abdominal incision had been made and before 
manipulation of the tumor, peritoneal washing was performed. Intraoperatively, 
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250 mL of saline were instilled into the abdominal cavity over the tumor site and at 
least 150 mL were reaspirated. Twenty mL were sent for cytological examination 
which was performed after Papanicolaou and Giemsa stainings. The slides were 
examined by light microscopy by experienced cytologists unaware of the clinical 
findings. Patients with suspicious morphological evidence of malignancy by 
microscopy were included in the positive cytology group. 
 
3.2.3 RNA extraction and cDNA synthesis 
 
Each peritoneal wash sample was centrifuged at 1200 rpm for 10’ and total RNA 
was extracted using the TRIzol method (Invitrogen, Carlsbad, CA, USA) according 
to the manufacture’s procedure. Briefly cells were homogenized in 1 mL TRIzol 
reagent and RNA was extracted by incubation and centrifugation in 0,2 mL CHCl3. 
RNA was precipitated from aqueous phase by 0,5 mL of isopropanol. RNA pellet 
was washed in 75% ethanol and eluted with 0,1% diethylpyrocarbonate (DEPC)-
treated water.  
Total RNA quantity, purity and absence of ribonuclease digestion were assessed by 
measuring the optical density ratio 260/280 nm. Total RNA samples were stored at 
-80°C. After denaturation in DEPC-treated water at 70°C for 10 min, 1 µg of total 
RNA was used to cDNA synthesis using cDNA synthesis mix (Bio-Rad 
Laboratories, Hercules, CA, USA).  
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3.2.4 Real-time PCR primer design 
 
Gene sequences were obtained from the NCBI database. Oligonucleotide primers 
for CEA and CK20 target genes and GAPDH housekeeping gene were chosen with 
the assistance of the Beacon Designer 7.0 computer program (Bio-Rad 
Laboratories). The primers sequences used throughout this study are described in 
the Table 2. For each primer pair, we performed no-template control and no-
reverse-transcriptase control (RT negative) assays, which produced negligible 
signals (usually >45 in threshold cycle (Ct) value), suggesting that primer dimer 
formation and genomic DNA contamination effects were negligible. 
Oligonucleotide primers were purchased from Invitrogen. 
 
3.2.5 PCR amplification 
 
Real-time PCR was performed using the iCycler Real-Time Detection System (iQ5 
Bio-Rad) with optimized PCR conditions. The reaction was carried out in a 96- well 
plate using iQ SYBER Green Supermix 2X (Bio-Rad) adding each forward and 
reverse primers and 1 µl of diluted template cDNA to a final reaction volume of 15 
µl. All assays included a negative control and were replicated three times. The 
relative expression of GAPDH was used for standardizing the reaction. The 
thermal cycling conditions comprised an initial denaturation step at 95°C for 3 
minutes, followed by 45 cycles at 95°C for 10 seconds and 60°C for 30 seconds. 
 
name Primer Forward Primer Reverse    Eff.% 
GAPDH 5’CATCAGCAATGCCTCCTGCAC3’ 5’GTCATGAGTCCTTCCACGATACCAA3’ 99.7 
CEA 5’AGGACAGAGCAGACAGCAGAG3’ 5’GGTTCCAGAAGGTTAGAAGTGAGG3’ 94.4 






Table 2. Primers sequence and amplification efficiency. 
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3.2.6 Data analyses 
 
Real-time quantitation was performed by using SYBR Green dye as fluorescent 
signal, with the help of the iCycler IQ optical system software version 3.0a (Bio-
Rad), according to the manufacturer’s manual. Quantitative values are obtained 
from the Ct number at which, the increase in signal associated with exponential 
growth of PCR products, starts to be detected. Target genes (CEA, CK20) 
amplification was compared with simultaneous amplification of an endogenous 
reference gene (GAPDH) and each sample was normalized on the basis of its 
GAPDH content.  
The target genes CEA and CK20 were tested for expression in tenfold serial 
dilutions (106-100) of cancer cell lines from colon (HT29, Caco2) and gastric (AGS) 
carcinoma. Normal human fibroblast cell line from colon (CCD18) and primary 
culture of human fibroblasts from skin were used as negative controls.  
For data analysis, receiver-operating characteristic (ROC) curves were used to 
compare the accuracies of CEA/GAPDH, CK20/GAPDH ratio and determine the 
cut off value by plotting sensitivity/specificity pairs for the two mRNA ratio. The 
clinical value of CEA and CK20 detection was assessed based on the diagnostic 
data from patients with positive cytology made at laparoscopy and from patients of 
the control group. The cut off value for CEA and CK20 was defined as 0.66 (gene 
target/GAPDH ratio). The sensitivity and specificity obtained at the determined 
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cut off were 77% and 100% respectively for the CEA/GAPDH ratio and 100% and 
93% for the CK20/GAPDH ratio. 
 
3.2.7 Immunomagnetic enrichment for epithelial cells 
 
From each patient, 40 mL of peritoneal wash were collected in EDTA (50 M). 
Samples were centrifuged at 1300 rpm for 6 min at 25°C and resuspended for 
magnetic labeling in 80 µL of MACS separation buffer (Miltenyi Biotec, Bergisch 
Gladbach, Germany). Immunomagnetic depletion using anti-CD45 microbeads 
(Miltenyi Biotec) was performed according to the manufacturer’s instructions to 
enrich for FPTCs (Figure 7A). Briefly, MS separation columns (MACS, Miltenyi 
Biotec) had been equilibrated with 0,5 mL of MACS separation buffer and the 
microbeads labeled cells were subjected to magnetic field trough the column 
passage. The CD45 negative cells were washed off from the column with 1,5 mL of 





CD45 negative cells were incubated with anti-CD326/EpCAM-FITC monoclonal 
Ab (1:10 in MACS separation buffer) for 15 min at 4°C (Figure 7C). Cells were 




Figure 7: A-C. Immunoenrichment and immunofluorescence methods to detect free 
disseminated peritoneal tumor cells (see text). D. Images of EpCAM/CEA positive 
FPTCs (yellow) surrounded by epithelial cells positive for EpCAM (green) or IF 
double negative inflammatory or mesothelial cells.  
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resuspended in 10 µL of cell solution and spotted on 8 wells diagnostic slides 
(Menzel-Glaser, Braunschweig, Germany), left to dry and fixed with acetone for 8 
min at -20°C. Cells were then incubated with anti-CEA polyclonal antibodies 
(Zymed, Invitrogen, Carlsbad, CA, USA) (1:100 in MACS separation buffer) for 1 
h at 25°C. After appropriate washing, the primary antibodies were visualized using 
goat anti-rabbit IgG-Texas Red (1:400 in MACS separation buffer) for 30 min at 
25°C. Nuclei were stained with DAPI (1 ng/mL, Sigma Chemicals, St Louis, MO, 
USA). Coverslips were finally mounted with mowiol for observation. Cells were 
analyzed by conventional fluorescence or by scanning in a series of 0.5 m 
sequential optical sections with an ApoTome System (Zeiss, Oberkochen, Germany) 
connected with an Axiovert 200 inverted microscope (Zeiss). Image analysis was 
performed by the Axiovision software (Zeiss). Single optical sections were acquired 





A cross-tabulation analysis of histopathological findings with qRT-PCR analysis,  
immunofluorescence evaluation and cytologic examination was performed by the 
chi-square test for trend or Fisher’s exact test. 
The analysis of cancer specific survival and time to recurrence rates was calculated 
using the Kaplan-Meier method and compared using the log-rank test.  
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Cox proportional-hazards regression was performed to analyze the effect of all 
variables on survival and recurrence times. 
A p value of 0.05 was considered as statistically significant. 
 
3.3  Results 
 
The application of immunomagnetic enrichment for epithelial cells and 
immunofluorescence analysis was performed in peritoneal lavages obtained from 
patients affected by gastric or colorectal cancers and this results were then 
associated and compared to the conventional cytology and to the molecular qRT-
PCR analysis for the expression of CEA and CK20 mRNA.  
For the immunomagnetic enrichment we used a consolidated method of 
immunodepletion of the inflammatory CD45+ cells, which are the major cell 
population present in the peritoneal washes. After depletion, the CD45- cells 
washed out from the column were immunolabeled for the epithelial marker 
CD326/EpCAM and for the tumor marker CEA: cells were then evaluated by 
immunofluorescence microscopy to search for the FPTCs (Figure 7A-C). In our 
analysis, only cells double positive for EpCAM and CEA were considered as 
FPTCs. In addition, careful observation of the cell nuclei stained by DAPI allowed 
to evaluate the cell viability and to exclude apoptotic or necrotic cells from our 
analysis (Fig 7D).  
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3.3.1 Relevance of free peritoneal tumor cells detection in gastric carcinoma 
 
Global positivity rate for cytology, IF and qRT-PCR was 15%, 15% and 78% 
respectively. Cytology was positive in only 4 patients with T4 tumours, which were 
also characterized by massive peritoneal carcinomatosis. All these 4 patients were 
positive qRT-PCR markers and three of them were positive to the IF too. 
Interestingly, one patient with minor peritoneal carcinomatosis was negative at the 
cytological examination, but positive at both IF and qRT-PCR analysis. Table 3 
shows the results for IF in gastric carcinoma patients. The chi-square test for trend 
showed how the worse grading (p=0.005), the deeper invasion of the gastric wall 
(p=0.01), the advanced stage of disease (p=0.014) and positive cytology (p=0.0014) 
are all related to the positivity at IF. 
The molecular qRT-PCR method showed a remarkably higher incidence of 
positivity: in fact, expression of the markers was over the cut-off level in all T2 and 
T4 patients, in 3 out of 6 of the T1 patients and in 5 out of 8 of T3 patients. 
Moreover, as shown in Figure 8, there was a clear higher positivity for CEA (70%) 
respect to CK20 (41%). The combination of positivity for CEA and CK20 was 
observed in 36% of patients.  
The positivity at qRT-PCR was not related to the depth of invasion, stage of disease 
and to the IF  positivity but also associated to the worse grading (p=0.008; table 4). 
The Kaplan-Meyer survival analysis showed how the positivity of IF and qRT-PCR 





Table 3. Correlation between immunofluorescence evaluation, cytologic 





Table 4. Relationship between qRT-PCR analysis, immunofluorescence evaluation 










Figure 8. Expression levels of CEA and CK20 mRNA in control subjects and 
gastric cancer patients.  
The cutoff values of CEA/GAPDH and CK20/GAPDH was 0.66. The open circles 
show the alive patients. The gray closed circles show patients who relapse. The 
black closed circles show patients who died by tumor-relates causes.  
 
 









Figure 10. Time to recurrence rates by qRT PCR positivity in gastric cancer 
 
 







Figure 12. Cancer specific survival rates by qRT PCR positivity in gastric cancer 
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specific overall survival  and disease free survival rates (Figures 9-12). At the 
multivariate analysis (Table 7), the stage at primary diagnosis was found to be an 
independent risk factor in overall survival only, while qRT-PCR resulted to be an 
independent risk factor in both overall and disease free survival with hazard ratio 
of 31.3 and 18.5 respectively (p<0.05). IF was found to be a statistically significant 
prognostic factor at univariate analysis (Figures 9 and 11), but it lost its prognostic 
power at multivariate analysis (Table 7). 
 
3.3.2 Relevance of free peritoneal tumor cells detection in colorectal carcinoma 
 
Global positivity rate for cytology, IF and qRT-PCR for FPTCs was respectively 0%, 
17% and 42%. Cytology was negative in all patients, including one patient with 
peritoneal carcinomatosis; this same patient resulted positive for both CEA and 
CK20 at the qRT-PCR, but negative at IF. As shown in Table 6, IF was found 
positive in similar proportions in T2 (1/6 cases, 17%), T3 (5/27 cases, 19%) and T4 
patients (2/14 cases, 14%). On the contrary of gastric carcinoma cases, posititive IF 
was not related to grading, depth of invasion and stage as shown in Table 5. In 
Table 6 are summarized the results for qRT-PCR: as well as the IF, no correlation 
was found between qRT-PCR and grading, depth of invasion and stage. Of the 8 
patients who resulted positive to the IF, 7 of them were positive to qRT-PCR too, 
indicating a strong correlation between IF and PCR in colorectal carcinoma 





Table 5. Correlation between immunofluorescence evaluation, cytologic 





Table 6. Correlation between qRT-PCR analysis, immunofluorescence evaluation 
and histopathological findings in colorectal carcinoma.  
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respect to CK20 (10%). In addition, all patients positive for CK20 were also positive 
for CEA.  
The analysis of survival was conducted on disease free survival only, due to the 
few tumor-related deaths occurred during the follow-up. Figured 14 and 15 shows 
the Kaplan-Meier survival curves for colorectal carcinoma patients: at Log-rank test 
worse prognosis was significantly associated to positive qRT-PCR (p=0.018) but not 
to IF (p=0.88). The multivariate Cox population analysis shows how qRT-PCR was 
found to be the only independent risk factor for relapse, with a hazard ratio of 6,95 
(p<0.05; table 8). 
 
3.3.3 Analysis of control patients 
 
All samples of peritoneal lavage from the control group resulted negative for 
cytology, IF and real time qRT-PCR. 
 
3.4  Discussion and conclusions 
 
Peritoneal cytology has been introduced by many institutions as prognostic marker 
in both gastric and colorectal cancer. In gastric cancer its importance has been 
increasing during the last years and it has been proposed to use percutaneous or 
laparoscopic peritoneal lavage in the preoperative staging of patients (La Torre et 
al., 2010). Actually in some cases positive peritoneal cytology from patients with 











Figure 13. Expression levels of CEA and CK20 mRNA in control subjects and 
colorectal cancer patients.  
The cutoff values of CEA/GAPDH and CK20/GAPDH was 0.66. The open circles 
show the alive patients. The gray closed circles show patients who relapse. The 
black closed circles show patients who died by tumor-relates causes.  
 
 



















Table 8. Multivariate Cox population hazards analysis for the colorectal cancer 
patients. 
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absolute contraindication to surgery. It has been clearly assessed from many studies 
its value as negative prognostic marker: although positivity for peritoneal cytology 
increases with the stage of the disease, it has been found from different studies how 
its prognostic significance is independent. In fact, analyzing patients from the same 
stage of disease, those with positive peritoneal cytology had worse prognosis. The 
7th TNM edition (Sobin LH, Gospodarowicz MK, Wittekind C. International Union 
Against Cancer (UICC) TNM classification of malignant tumours, 7th edition. New 
York: Wiley-Liss; 2010) has given great importance to peritoneal cytology, 
including in the M1 group those patients with positive washings even in absence of 
visible peritoneal implants. 
In colorectal cancer the use of peritoneal cytology is less used and standardized 
than in gastric cancer, probably for the minor incidence of peritoneal 
carcinomatosis in this type of neoplasm. Most studies on patients affected with 
colorectal cancer show that the detection of single cancer cells in peritoneal cavity 
has prognostic relevance (Schott et al., 1998; Noura et al., 2009), but in other cases 
results were different (Wind et al., 1999). 
The primary problems with conventional peritoneal cytology are the lack of 
sensitivity (positivity of 14-21% in gastric cancer and 0-11% in colorectal cancer) 
and the high operator-dependent feature of this test. In fact most of patients with 
positive peritoneal lavage develop peritoneal carcinomatosis, but it is even 
developed by many of the patients with negative peritoneal washing. Since the 
knowledge about the presence of isolated tumor cells in the peritoneal cavity has 
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been growing in importance for the treatment strategy in both gastric and colorectal 
cancer, clinicians need new and more sensitive and specific techniques to retrieve 
these new prognostic factors. The simplest technique that gives little advantage on 
the results of traditional cytopathology is to integrate it with immunocytochemical 
methods, using monoclonal antibodies directed to gastric cancer-associated 
antigens (Benevolo et al., 1998). 
Kodera et al. (Kodera et al., 2002) proposed the use of real time qRT-PCR for the 
detection of free peritoneal tumor cells from patients affected with gastric cancer: a 
greater sensitivity of real time qRT-PCR was reported in comparison with cytology: 
all patients who presented peritoneal carcinomatosis during the follow up period 
were positive at time of surgery for real time qRT-PCR on peritoneal washes and 
omentum while only about 30% of them were positive even for conventional 
cytology.  
After 1998 some more Authors, mostly Japanese, reported about the use of real time 
qRT-PCR for the detection of isolated peritoneal tumor cells from gastric cancer 
patients and all of them concluded confirming how real time qRT-PCR is a more 
specific and sensitive technique than cytopathology and that it was found to be as 
independent prognostic marker. Similar studies about colorectal cancer are also 
present in the literature, but less frequently. In their study Guller et al. (Guller et al., 
2002) report  that, on a total of 39 colorectal cancer patients, 10 of them resulted 
positive for the RT-PCR (CEA and CK20) at the peritoneal lavage. During the 
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follow up period 8 of them had recurrence and positive peritoneal real time qRT-
PCR was found to be an independent prognostic factor. 
Hara et al. (Hara et al., 2007) published the first and only study comparing the 
results of RT-PCR on peritoneal lavage in gastric and colorectal cancer patients. 
They found that prognosis in positive RT-PCR patients was worse in both 
colorectal and gastric cancer; they also found that, among real time qRT-PCR 
positive cases, peritoneal carcinomatosis was significantly more frequent in gastric 
cancer patients but not in colorectal patients. They concluded stating that colorectal 
carcinoma cells must have some biological characteristics that make them with a 
low-peritoneal metastatic potential. 
Some criticism have been moved to this molecular technique, since some Authors 
believe that the expression of some genes used for the identification of tumor cells 
may be present in inflammatory cells as well,  resulting real time qRT-PCR in a 
high sensitivity and low specificity test (Kowalewska et al., 2008).  
Some problems about the optimization of the molecular techniques still have to be 
debated: for example, the possibility of high rate of false positive diagnosis at RT-
PCR. This can be due to an illegitimate expression of marker genes in noncancerous 
cells (Goeminne et al., 1999) or to a too high sensitivity of the technique that can 
even detect mRNA markers from a very small, clinically insignificant, number of 
cells. Nevertheless in some Japanese Institutions real time qRT-PCR is already used 
in the clinical practice: patients with negative cytology and positive real time qRT-
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PCR at preoperative staging laparoscopy are treated with a short-term 
intraperitoneal chemotherapy (Mori et al., 2004). 
To our knowledge nothing is reported about the use of IF for the detection of free 
peritoneal cancer cells in enriched samples of peritoneal lavages. Our study 
combined for the first time the use of real time qRT-PCR with IF and 
immunomagnetic enrichment of epithelial cells to detect free peritoneal tumor cells 
in gastric and colorectal cancer. For each technique we used two different markers: 
CEA and CK20 for the qRT-PCR and CEA and EpCAM for IF. Our results 
confirmed the low sensitivity of the traditional cytology: in fact, it was positive only 
in four cases of gastric cancer with associated massive peritoneal carcinomatosis 
and in none of colorectal cancers. All cytological positive samples resulted positive 
also for IF and real time qRT-PCR. On the contrary, no false positive were found at 
the qRT-PCR or IF examination in the group of patients with non-malignant 
diseases, further demonstrating the validity of our procedure.  
In comparison with cytology, both IF and real time qRT-PCR showed higher 
positivity rates, being 15% and 78% for gastric cancer patients and 17% and 42% for 
colorectal cancer patients respectively. Among the gastric cancer patients, IF was 
positive not only in the 3 of them with massive carcinomatosis, but also in 1 case 
with minor extent of peritoneal dissemination. Interestingly, in colorectal cancer 
patients we found positivity even in early stages of disease.  
The positivity rate for qRT-PCR in gastric cancer patients was impressive, 
comprising more than 3/4 of the patients, distributed in all T1-T4 stages of disease. 
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In contrast, in colorectal cancer patients the qRT-PCR positivity was found in less 
than half of patients, most of them with T3-T4 disease. All patients positive at IF 
were also positive at qRT-PCR, except for one colon cancer and one gastric cancer 
patients.  
Our data showed how positive IF resulted to be significantly associated to grading, 
depth of invasion, stage of disease and cytology in gastric cancer. On the opposite 
for colorectal cancer IF was note related to any of the examined clinicopathological 
factors. In the survival study positive IF was associated to worse overall and 
disease free survival in gastric patients at the univariate analysis; at the 
multivariate analysis IF was not found to be an independent prognostic factor in 
gastric cancer patients. In colorectal cancer cases IF was not a statistically significant 
prognostic factor in both univariate and multivariate analysis.  
RT-PCR positivity was associated to higher grading in gastric cancer and only to 
positive IF in colorectal cancer. In both gastric and colorectal cancer RT-PCR was 
found to be one of the strongest independent prognostic factors. 
From these data we can notice that IF seems to be associated to the most common 
clinicopathological factors in GC, but it has no prognostic value in both gastric and 
colorectal cancer patients. On the other hand RT-PCR is not frequently associated to 
other clinicopathological factors but resulted to be independently relevant for the 
prognosis in both gastric and colorectal cancer.  
In conclusion, we believe that the combination of conventional real time qRT-PCR 
with immunoenrichment and IF, which permit morphological assessment and 
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unequivocal identification of the FPTCs as well as validation of the molecular 
analysis, could be an useful and more powerful procedure for the detection of free 
peritoneal tumor cells. More studies on these cells are requested to understand their 
prognostic power and any other possible clinical application. Since the treatment of 
cancer is going toward the personalized therapy, as well as for the circulating 
tumor cells, in the future the characterization of peritoneal tumor cells may be 
interrogated to guide molecularly targeted therapies, assess treatment effect and 
detect development of drug resistance. 
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